enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Read current and featured research from the Journal of Medicinal Chemistry on ACS Publications, a trusted source for peer-reviewed journals.

  3. Read the latest ASAP articles from the Journal of Medicinal Chemistry on ACS Publications, a trusted source for peer-reviewed journals.

  4. ABSTRACT. Murine double minute X (MDMX) is an oncoprotein that mainly has a negative regulatory effect on the tumor suppressor p53 to induce tumorigenesis. As MDMX is highly expressed in various types of tumor cells, targeting and inhibiting MDMX are becoming a promising strategy for treating cancers.

  5. Check out a complete list of issues for the Journal of Medicinal Chemistry on ACS Publications, a trusted source for peer-reviewed journals.

  6. Journal of Medicinal Chemistry. Findings on the relationship between molecular structure and biological activity or mode of action in drug discovery and development. Editor-in-Chief: Craig W. Lindsley, Vanderbilt University Medical Center. jmc@jmedchem.acs.org.

  7. Journal of Medicinal Chemistry 2020, 63, 22, XXX-XXX (Article) Publication Date (Web): November 25, 2020. PDF. Read research published in the Journal of Medicinal Chemistry Vol. 63 Issue 22 on ACS Publications, a trusted source for peer-reviewed journals.

  8. Journal of Medicinal Chemistry 2021, 64, 1, XXX-XXX (Article) Publication Date (Web): January 14, 2021. PDF. Read research published in the Journal of Medicinal Chemistry Vol. 64 Issue 1 on ACS Publications, a trusted source for peer-reviewed journals.

  9. Journal of Medicinal Chemistry Author Information – ACS...

    pubs.acs.org/page/jmcmar/submission/authors.html

    The Journal of Medicinal Chemistry adheres to the American Chemical Society Ethical Guidelines to Publication of Chemical Research standards regarding the use of animals in research.

  10. Discovery of ZLC491 as a Potent, Selective, and Orally...

    pubs.acs.org/doi/10.1021/acs.jmedchem.4c01596

    Selective degradation of cyclin-dependent kinases 12 and 13 (CDK12/13) emerges as a new potential therapeutic approach for triple-negative breast cancer (TNBC) and other human cancers.

  11. View the Editorial Board for the Journal of Medicinal Chemistry and get contact information for associated members.